NCT02985294

Brief Summary

This study evaluates peripheral nervous system function using Multiple Excitability Measures (MEM) to obtain "electrophysiological pain phenotypes"

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 7, 2016

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

August 23, 2018

Status Verified

August 1, 2018

Enrollment Period

2.9 years

First QC Date

November 28, 2016

Last Update Submit

August 21, 2018

Conditions

Keywords

Neuropathic painQuantitative Sensory TestingMultiple Excitability MeasuresThreshold Tracking

Outcome Measures

Primary Outcomes (2)

  • Electrophysiological pain phenotypes using MEM. Pain biomarker

    Correlate with parameters of clinical pain and of pain processing in existing pain patients

    Single assessment (cross sectional study) at the first and only visit

  • Electrophysiological pain phenotypes using MEM. Pain predictor

    Predict development of neuropathic pain in susceptible patients

    Single assessment at baseline, before any procedure (surgery/chemotherapy)

Study Arms (2)

Cross-sectional cohort

Multiple Excitability Measures of peripheral nerves on patients with chronic peripheral neuropathic pain

Other: Multiple Excitability Measures of peripheral nerves

Longitudinal cohort

Multiple Excitability Measures of peripheral nerves on painless patients before and after potential chronic neuropathic pain-inducing interventions (chemotherapy, surgery)

Other: Multiple Excitability Measures of peripheral nerves

Interventions

The technique of threshold tracking can be used to obtain several measures of peripheral nerve excitability (Multiple Excitability Measures or MEM), such as refractoriness, supernormality, strength-duration time constant and 'threshold electrotonus' (i.e. the changes in threshold produced by long-lasting depolarizing or hyperpolarizing current pulses). Each of these measurements depends on membrane potential and on other biophysical properties of the axons. Many of these excitability parameters are very constant among different subjects, while other, such as the current/threshold parameters and the super/sub-excitability parameters, appear to be characteristic of an individual

Also known as: Assessment of sensory phenotype by QST (quantitative sensory testing), Questionnaires
Cross-sectional cohortLongitudinal cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

1. Painless patients and patients with chronic peripheral neuropathic pain 2. Susceptible patients for developing pain i. Undergoing surgical procedures associated with a relatively high risk of developing neuropathic pain such as thoracotomy and hernia repair ii. Planning to start chemotherapy with potentially neurotoxic agents such as taxol, vincristine, etc.

You may qualify if:

  • Chronic peripheral neuropathic pain
  • Painless Patient with risk to develop neuropathic pain (post-surgery, chemotherapy-induced)

You may not qualify if:

  • Minors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neuroscience technologies

Barcelona, 08028, Spain

RECRUITING

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

blood sample

MeSH Terms

Conditions

PolyneuropathiesPeripheral Nerve InjuriesPeripheral Nervous System DiseasesNeuralgia

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neuromuscular DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Romà Solà, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2016

First Posted

December 7, 2016

Study Start

April 1, 2016

Primary Completion

March 1, 2019

Study Completion

April 1, 2020

Last Updated

August 23, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations